Non-communicable diseases (NCDs) are responsible for 60% of global deaths and affect individuals of all ages, nationalities, and classes (
1). These diseases may be chronic or acute and include most cardiovascular diseases (CVDs), cerebrovascular attacks (CVAs), diabetes, most cancers, autoimmune diseases, neurological disorders, such as Parkinson’s disease and Alzheimer’s disease, skeletal disorders, such as osteoarthritis and osteoporosis, chronic kidney disease, cataracts, and other conditions and diseases (
2). The mortality from NCDs, and specifically, the major CVDs (CVA, hypertension), metabolic diseases (obesity, diabetes), and lung diseases (COPD), is double that of a combination of infectious diseases (including tuberculosis (TB), malaria, and human immunodeficiency virus infection/acquired immune deficiency syndrome (HIV/AIDS)), maternal and perinatal conditions, and nutritional deficiencies (
3). The significance of NCD reduction has further been stressed with the recent rise of the novel coronavirus COVID-19 pandemic that mainly resulted in the deaths of those with pre-existing NCDs. The major pre-existing conditions (comorbidities) resulting in death in individuals infected with COVID-19 are/were the main NCDs, namely (in descending order of contribution to mortality); cardiovascular disease, diabetes, chronic respiratory disease, hypertension, followed by cancer (
4,
5).
Moreover, while the prevention of morbidity and mortality from NCDs gets scant consideration in Sub-Saharan Africa and worldwide, the massive mobilization of resources for the HIV/AIDS response has been unmatched in the history of public health (
3). Even in low- to middle-income countries (LMIC), US$19.1 billion (57% from domestic resources) was made available for the HIV/AIDS response in LMICs in 2016 (
6). Of the 35 million deaths associated with NCDs annually, approximately 80% are in LTMICs (
1) and in low-resource settings, such as South Africa (
7). These NCDs exhort a considerable effect on individuals and healthcare structures (
1), and in most cases, it is the economically-productive workforce that is affected by these NCDs (
8).
Fortunately, NCDs are largely preventable (
9) and research is unequivocal that NCD mortality and morbidity can be limited through appropriate public health strategies focusing on the control of risk factors (
10). The rise of NCDs has been driven by primarily three modifiable, and thus preventable, risk factors, namely, physical inactivity, unhealthy diets, and tobacco use (
8). Specifically, evidence has demonstrated at almost 80% of premature deaths from CVD, CVA, and diabetes can be avoided with already established pharmaceutical and behavioral intercessions (
8). However, to lessen the impact of NCDs on individuals, societies, and health systems, a comprehensive approach is needed. Problematically, while there has been considerable application of expensive interventions in many LMICs, evidence suggests that already proven, low-cost prevention strategies, such as exercise rehabilitation, are not being employed (
11). Despite the World Health Organization (WHO) publishing a seminal report in 1993 entitled ‘Rehabilitation after cardiovascular diseases, with special emphasis on developing countries’, recommending how exercise interventions could be provided in low-resource settings (
12), formalized exercise rehabilitation is only available in approximately one-tenth of low-income countries (LICs) and one-quarter of medium-income countries (MICs) (
13). While the reasons for the lack of availability of formalized exercise rehabilitation settings are complex, some reasons include the scarcity of randomized trials examining exercise rehabilitation in LMICs (
14), and the lack of strategies regarding the optimal implementation of exercise for disease prevention in low-resource settings (
12).
Exercise rehabilitation as an approach to health promotion, NCD risk reduction, and NCD rehabilitation/management has almost exclusively focused on cardiorespiratory forms of exercise (
15). In this regard, walking continues to be the touchstone when prescribing programs for exercise rehabilitation (
15). Even in LMICs, walking (either as part of the structured exercise or as active forms of transportation) and step counting for 6500 - 10000 steps per day is one of the most popular recommendations to presumably meet the recommendations to accumulate 150 minutes of physical activity per week (
16,
17). This is despite this mode of exercise consistently being demonstrated to not meet minimum intensity guidelines for health improvement (
18). This is problematic in that evidence indicates that resistance training effects are equal to and sometimes superior to that of cardiorespiratory training (
15). In addition, the effects on both fitness and health are enhanced when resistance training is added to cardiorespiratory training (
15,
19). In addition, as demonstrated by the global lockdowns observed during the COVID-19 pandemic, significant proportions of the globe were confined to their homes where they were unable to engage in cardiorespiratory forms of exercise due to an inability to leave their homes to exercise outside, lack of space indoors and/or a lack of related personal equipment (such as treadmills, indoor/personalized pools, etc.); making resistance training a more practical solution to the continued curbing and management of NCDs.
Given the rapid increase in NCDs worldwide, it is essential to establish a safe, simple, but effective, low-cost intervention for halting the development of NCDs and their management once diagnosed, especially in low-resource settings. Thankfully, low-cost resistance training (using calisthenics, Pilates, elastic tubing, etc.) has proven equally effective to conventional resistance training using weight machines in improving several health parameters (
20-
23). Understanding and reporting on the successful use of resistance training in exercise settings for health promotion, NCD risk reduction, and NCD rehabilitation/management may offset the reported low uptake of resistance training in such settings and may reduce the ever-increasing morbidity and mortality associated with NCDs.